Covidien, Agency Urge Justices To Skip AIA Process Case
Health products company Covidien and the U.S. Patent and Trademark Office have challenged a Johnson & Johnson unit's assertion that the America Invents Act bars the Patent Trial and Appeal Board...To view the full article, register now.
Already a subscriber? Click here to view full article